Science Weekly

Science Weekly

Twice a week, the Guardian brings you the latest science and environment news
00:00
00:00

Rezumatul episodului

You Can See Everything, a documentary about the disgraced biotech company founder Elizabeth Holmes, has enjoyed a record-breaking opening in the US. It is a testament to how fascinated we remain by the convicted fraudster, but what is behind the enduring appeal? US technology editor Blake Montgomery tells Madeleine Finlay why Holmes continues to fascinate us, and reflects on whether the Theranos scandal has had a permanent impact on Silicon Valley. Help support our independent journalism at <a href="https://www.theguardian.com/sciencepod">theguardian.com/sciencepod</a>

Episoade

1339-

Elizabeth Holmes is back in the spotlight: why can’t we look away?

You Can See Everything, a documentary about the disgraced biotech company founder Elizabeth Holmes, has enjoyed a record-breaking opening in the US. It is a testament to how fascinated we remain by the convicted fraudster, but what is behind the enduring appeal? US technology editor Blake Montgomery tells Madeleine Finlay why Holmes continues to fascinate us, and reflects on whether the Theranos scandal has had a permanent impact on Silicon Valley. Help support our independent journalism at <a href="https://www.theguardian.com/sciencepod">theguardian.com/sciencepod</a>

22 oct. 2026
1338-

‘These risks are real’: the threat of AI bioweapons

In his annual speech on threats to the nation, Sir Ken McCallum, the head of the UK’s intelligence service, MI5, warned that AI had the potential to ‘change the stakes’ on existing and even new bioweapons. To find out why, and how, Ian Sample speaks to Dr Tom Inglesby, director of the Johns Hopkins Center for Health Security and the Bloomberg School of Public Health. He explains what has governments so worried and what measures could be put in place to reduce the risks. Help support our independent journalism at <a href="https://www.theguardian.com/sciencepod">theguardian.com/sciencepod</a>

20 oct. 2026
1337-

Is your boss watching you? The rise of AI surveillance at work

Workers have always been monitored by their bosses, first through output targets, and then via computer software labelled ‘bossware’. But AI is transforming the capabilities of these systems, processing huge volumes of data to provide minute-by-minute accounts of activity, and productivity. To find out more, Ian Sample hears from UK technology editor Robert Booth. He explains which sectors are adopting this approach, why they are doing it, and how it could end up being counterproductive.. Help support our independent journalism at <a href="https://www.theguardian.com/sciencepod">theguardian.com/sciencepod</a>

15 oct. 2026
1336-

The surprising psychology of morbid curiosity

US defence secretary Pete Hegseth’s plan to livestream the execution of Nidal Malik Hasan has incurred condemnation from human rights groups and politicians on all sides. But according to Coltan Scrivner, an author and psychologist at Arizona State University and expert on morbid curiosity, people are still likely to watch in large numbers. He explains why we are drawn to dark and disturbing content, and Madeleine Finlay tells Ian Sample how consuming this kind of material can harm observers’ mental health. Help support our independent journalism at <a href="https://www.theguardian.com/sciencepod">theguardian.com/sciencepod</a>

13 oct. 2026
1335-

All the news and science from the 2026 Nobel prizes

This year’s Nobel prizes in chemistry, physics and physiology or medicine have celebrated work that has been used to develop countless drugs and transform modern medicine, allowed physicists to observe one of the most mysterious particles, and provided a tool that could act as an on/off switch for brain cells. To find out more, Madeleine Finlay talks to our science editor, Ian Sample, and correspondents Nicola Davis and Linda Geddes. Help support our independent journalism at <a href="https://www.theguardian.com/sciencepod">theguardian.com/sciencepod</a>

07 oct. 2026